
Results
189
Companies which are potentially undervalued and in an acceptable financial position.
189 companies
Amphastar Pharmaceuticals
Market Cap: US$842.2m
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$19.30
7D
6.3%
1Y
-24.7%
Verastem
Market Cap: US$373.5m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$4.29
7D
0.5%
1Y
-44.8%
Zevra Therapeutics
Market Cap: US$647.3m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.40
7D
8.7%
1Y
32.3%
High Tide
Market Cap: CA$290.1m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.44
7D
2.1%
1Y
13.9%
Tasly Pharmaceutical Group
Market Cap: CN¥21.0b
Engages in the research, development, production, and sale of pharmaceuticals in China.
600535
CN¥14.07
7D
-0.8%
1Y
-13.8%
Caris Life Sciences
Market Cap: US$4.3b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$16.67
7D
4.6%
1Y
n/a
Arcutis Biotherapeutics
Market Cap: US$2.6b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$21.44
7D
2.0%
1Y
56.8%
Cipher Pharmaceuticals
Market Cap: CA$420.8m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$16.51
7D
-2.2%
1Y
33.1%
Regeneron Pharmaceuticals
Market Cap: US$63.9b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$621.52
7D
-3.3%
1Y
2.7%
CorMedix
Market Cap: US$661.3m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.42
7D
5.5%
1Y
-30.6%
Innovent Biologics
Market Cap: HK$144.9b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$83.35
7D
3.0%
1Y
34.5%
Kissei Pharmaceutical
Market Cap: JP¥161.2b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,890.00
7D
-6.4%
1Y
-9.3%
Sanofi
Market Cap: €91.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€75.29
7D
-2.1%
1Y
-14.0%
Elanco Animal Health
Market Cap: US$11.8b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.98
7D
12.5%
1Y
77.4%
Alembic Pharmaceuticals
Market Cap: ₹144.7b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹736.10
7D
-2.6%
1Y
-27.7%
Dong-A Socio Holdings
Market Cap: ₩598.6b
Engages in the pharmaceutical business in South Korea.
A000640
₩90,300.00
7D
-2.5%
1Y
-16.9%
Yunnan Baiyao GroupLtd
Market Cap: CN¥89.1b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥49.94
7D
0.3%
1Y
-11.6%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥56.8b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥23.25
7D
-0.6%
1Y
-8.4%
Bayer
Market Cap: €37.2b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€36.53
7D
-5.1%
1Y
47.7%
Hugel
Market Cap: ₩2.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩248,500.00
7D
-7.1%
1Y
-25.2%
Collegium Pharmaceutical
Market Cap: US$1.1b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$33.37
7D
-3.1%
1Y
14.4%
Ardelyx
Market Cap: US$1.5b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.25
7D
-1.6%
1Y
55.1%
Dong-E-E-Jiao
Market Cap: CN¥32.1b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥49.99
7D
0.9%
1Y
-8.8%
Bavarian Nordic
Market Cap: DKK 14.3b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 188.00
7D
-4.6%
1Y
8.7%
Diaceutics
Market Cap: UK£120.2m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.43
7D
-14.1%
1Y
4.0%
Tarsus Pharmaceuticals
Market Cap: US$2.6b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$59.54
7D
-6.2%
1Y
37.1%
Fennec Pharmaceuticals
Market Cap: US$346.3m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$9.89
7D
-0.8%
1Y
22.1%
Journey Medical
Market Cap: US$164.9m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.20
7D
-0.2%
1Y
-23.2%
Decibel Cannabis
Market Cap: CA$72.1m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
-7.7%
1Y
84.6%
Genscript Biotech
Market Cap: HK$29.9b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$13.68
7D
5.5%
1Y
6.7%
Amoy Diagnostics
Market Cap: CN¥7.9b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥20.41
7D
7.6%
1Y
-2.2%
Dong-A ST
Market Cap: ₩384.5b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩40,000.00
7D
-4.5%
1Y
-13.4%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥13.1b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥8.08
7D
-1.6%
1Y
-28.2%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.22
7D
-3.2%
1Y
-14.1%
Exagen
Market Cap: US$121.0m
Designs, develops, and commercializes various testing products under the AVISE brand in the United States.
XGN
US$5.08
7D
19.0%
1Y
-27.2%
Perrigo
Market Cap: US$1.5b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$11.44
7D
0.8%
1Y
-57.8%